TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Time to appearance of grade 2 or >RD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Skin recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: clinical pregnancy based on sac rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Axial and Tinetti scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait recordings (double-stance duration, swing phase duration, step width, step length, velocity, cadence)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NSE serum levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: intention to use e‐cigarettes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: harm perception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: appeal to the product
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: AOFAS midfoot score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alignment of the first metatarsal (Meary angle)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiologic signs of osteoarthritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: relapse risk (RR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Service use over time
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction in daily smoking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum copeptin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival within 24 hours after ROSC
Endpoint domain: Mortality/survival
Primary endpoint: incidence of composite adverse birth outcome
Endpoint domain: Adverse events/effects
Primary endpoint: Accuracy of ear exam findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of repeat supervisor exams
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Outpatient visits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychiatric outpatient treatment adherence
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: self‐efficacy of rehabilitation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: weight change over 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post‐Concussion Symptom Inventory change score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma IL-6 and IL-10 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Endurance test improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strength test improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in FACT-ES physical well-being subscale score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Freedom from atrial tachycardia/AF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical worsening event
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported breastfeeding challenges
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Diagnostic performance of liver fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of mitral regurgitation (MR) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma levels of IL‐6, IL‐8, hs‐CRP, TNF‐α
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CD4+ and CD4/CD8 ratio levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: emotional ability and social ability
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient self-assessment scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Median time to TOFr = 0.9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: p16INK4a protein expression in endothelial progenitor cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of residual tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: 12-month eczema incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Quality of Life (QOL) utility weights
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: postoperative stone-free rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total duration of the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Trial attrition
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: patients' pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinician’s field of view
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to hand hygiene
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: grade 3 radiation dermatitis
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy against virologically‐confirmed dengue (VCD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Efficacy against hospitalized VCD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: PTSD severity measured by CAPS-5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PTSD severity measured by PCL-5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Awareness of musculoskeletal contributions to migraine
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Perceptions of chiropractic care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Chiropractor–patient relationship
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Deep abdominal muscle thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Trunk mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of GP contacts regarding ED
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Decrease in biofilm-forming bacteria colonies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: CVA (Cervical Vascular Assessment)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SSA (Shoulder Stability Assessment)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Control of delirium after initial bolus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Control of delirium after 4-hour infusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in agitation scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: restoration of dipping rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: arterial elasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Craving for MA
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: BFMDRS movement score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: concussion-reporting intention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: consideration of risk-reducing surgical procedures
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: postoperative PRC transfusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Helicobacter pylori prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Upper gastrointestinal bleeding complications
Endpoint domain: Adverse events/effects
Primary endpoint: Prognosis improvement after AMI
Endpoint domain: Mortality/survival
Primary endpoint: MOXFQ total score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction of the malleolar circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cost-effectiveness of web-based intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Lumbar spine range of motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chest wall mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incontinence-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Hemodynamic indexes (MAP, HR, CVP values)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence rates of postoperative complications (EA, hypoxemia, cardiovascular response, delayed recovery, headache)
Endpoint domain: Adverse events/effects
Primary endpoint: Understanding of notes
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Perceived usability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Tissue length biopsied
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of adverse events through week 24
Endpoint domain: Adverse events/effects
Primary endpoint: LAP (Lipid Accumulation Product)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: disease-specific distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean fear scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: THINC-it Codebreaker mean response time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: THINC-it Trails total response time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Dysfunctional sexual beliefs score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biological Effective Dose (BED) prediction accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of fall
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: same day acceptance of modern contraceptives
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: heart-rate variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: initial power output during the TT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complication-free admissions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: bed-days saved
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: postoperative mucociliary clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in nausea numeric rating scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deep capillary blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Superficial oxygen tissue saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postcapillary venous filling pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anti-obesity effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Flexion range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative hypocalcemia episodes
Endpoint domain: Adverse events/effects
Primary endpoint: Semen routine indexes improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TCM syndrome scores reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite end point of fatal and nonfatal ischemic events
Endpoint domain: Mortality/survival
Primary endpoint: Cmax of fluzoparib in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of fluzoparib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: eGFR and Pox correlation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Resting Motor Thresholds (rMTs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Motor Evoked Potentials (MEPs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Health Behavior Inventory scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pediatric Quality of Life Inventory scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: GAIS scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Vitamin A Deficiency (VAD) prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of familial hypercholesterolemia (FH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of patient navigation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: burnout
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to complete ETT fixation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: binocular indirect ophthalmoscopy performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: confidence in ability to perform the technique
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Work time impaired
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Risk of cognitive failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Deterioration in executive function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Learning and memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence rate of hypoglycemia < 3.9 mmol/L
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence rate of hypoglycemia < 3.0 mmol/L
Endpoint domain: Adverse events/effects
Primary endpoint: severe CVD events
Endpoint domain: Mortality/survival
Primary endpoint: FVIII recovery at 30 minutes post‐rFVIII infusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Diuretic index at 72 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ankle dorsiflexor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ankle pROM during foot supination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ankle pROM during foot pronation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Neuropeptidic levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KT ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-month CDP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 6-month confirmed worsening in CPS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: change of mouth smell
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of lymphedema
Endpoint domain: Mortality/survival
Primary endpoint: costs of treatment for lymphedema
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: reaction time reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite of all-cause mortality or new Q-wave myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: incident dementia risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: patient understanding
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: usefulness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: identifying next steps
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Providers' usage behaviour
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Perceived usefulness of the tool
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Behavioural intention to use the tool
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in clinic systolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in resting baroreflex sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: forced inspiration movement of the ipsilateral diaphragm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: weight-for-height z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 96-h survival rates
Endpoint domain: Mortality/survival
Primary endpoint: neurologic deficit scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Right ventricular dysfunction identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean OAI‐23 adjustment score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Failure rate of upper Memotain® retainers
Endpoint domain: Adverse events/effects
Primary endpoint: Knowledge of house environment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mental, cognitive, and spiritual well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: dual task walking speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Go/No-Go test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Step Reaction Time test (SRTT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LI symptom composite score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: milk and dairy intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global assessments improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: R value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: K value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relative decline of ≥10% in %FVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: death up to 1 year post-randomization
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in SNR50
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in APHAB scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improvement in SSQ scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Global Rating of Change (GRoC)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Shoulder abduction AROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion rate of randomized participants
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Group acceptability levels
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: average LLT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in symptoms reported on symptom surveys
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: HBV DNA levels below the lower limit of quantification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IES-R-J total score improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: TSCC-J sexual concerns subscores improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: DKA incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptability of HPV self-testing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in oral hygiene parameters (API and SBI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urologic complications
Endpoint domain: Adverse events/effects
Primary endpoint: Cognitive development score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning